MedPath

Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?

Recruiting
Conditions
Miscarriage, Recurrent
Miscarriage
Infertility, Female
IVF
Registration Number
NCT05969574
Lead Sponsor
ART Fertility Clinics LLC
Brief Summary

This study aims to explore the potential correlation between decreased ovarian reserve and previous history of early miscarriage.

Detailed Description

By investigating the prevalence of low ovarian reserve (LOR) in populations with specific reproductive histories (such as recurrent pregnancy loss, G0, and ectopic pregnancy), as well as the aneuploidy rates of embryos produced with Preimplantation Genetic Testing for Aneuploidies (PGT-A), Investigators can better understand how LOR impacts fertility outcomes in these populations. This information can be used to inform clinical decision-making, such as whether participants with LOR should consider alternative or whether they would benefit from additional interventions to improve ovarian function.

Ultimately, by improving our understanding of how LOR impacts fertility outcomes in specific populations, Investigators can help to improve the overall success rates of infertility treatment, reduce anxiety, and distress, and help participants achieve goals of becoming parents.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
2059
Inclusion Criteria
  1. All participants with at least 1 previous pregnancy, who are assessed in one of our clinics (ART Fertility Clinics Abu Dhabi, Al Ain, Dubai)
Exclusion Criteria
  1. Severe male factor (azoospermia, cryptozoospermia, severe oligoasthenoteratozoospermia (OAT))
  2. Severe Endometriosis and adenomyosis based on positive anamnesis or ultrasound performed in our center during the first consultation
  3. Uterine abnormalities (e.g. fibroids, different degrees of uterine septum), diagnosed by ultrasound
  4. History of ovarian surgery, chemotherapy, or radiation therapy
  5. Known genetic disorder or chromosomal abnormality
  6. BMI >40Kg/m2
  7. Currently using hormonal contraception or hormone replacement therapy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AFC1 day

Antral follicle count

AMH1 day

Anti-Müllerian Hormone Test

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

ART Fertility Clinics LLC

🇦🇪

Abu Dhabi, United Arab Emirates

ART Fertility Clinics Al Ain

🇦🇪

Al Ain, United Arab Emirates

ART Fertility Clinics Dubai

🇦🇪

Dubai, United Arab Emirates

ART Fertility Clinics LLC
🇦🇪Abu Dhabi, United Arab Emirates
Laura Melado, PhD
Contact
Jonalyn Edades, RN
Contact
+971 800 337845489
jonalyn.edades@artfertilityclinics.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.